Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01318434
Recruitment Status : Completed
First Posted : March 18, 2011
Last Update Posted : December 4, 2015
Sponsor:
Information provided by (Responsible Party):
Euthymics BioScience, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2013
  Actual Study Completion Date : February 2013
  Certification/Extension First Submitted : August 11, 2015